H.R. 4813 · 117th Congress · House

Matt’s Act

Active· Referred to the Subcommittee on Health.
Introduced
Jul 29, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Matt's Act

This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge uninsured individuals the average price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.

Action Timeline

5
  1. JUL 30, 2021•Committee

    Referred to the Subcommittee on Health.

  2. JUL 29, 2021•IntroReferral

    Introduced in House

  3. JUL 29, 2021•IntroReferral

    Introduced in House

  4. JUL 29, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. JUL 29, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

3

Health Subcommittee

hsif14

Referred: Jul 30, 2021

Active

Education and Workforce Committee

hsed00

Referred: Jul 29, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Jul 29, 2021

Active